These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34968763)

  • 1. Computational identification of Plasmodium falciparum RNA pseudouridylate synthase as a viable drug target, its physicochemical properties, 3D structure prediction and prediction of potential inhibitors.
    Afolabi R; Chinedu S; Ajamma Y; Adam Y; Koenig R; Adebiyi E
    Infect Genet Evol; 2022 Jan; 97():105194. PubMed ID: 34968763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
    Kumari M; Chandra S; Tiwari N; Subbarao N
    BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico identification of promiscuous scaffolds as potential inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase for treatment of Falciparum malaria.
    Wadood A; Ghufran M; Hassan SF; Khan H; Azam SS; Rashid U
    Pharm Biol; 2017 Dec; 55(1):19-32. PubMed ID: 27650666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel putative inhibitor of the Plasmodium falciparum purine nucleoside phosphorylase: exploring the purine salvage pathway to design new antimalarial drugs.
    Kagami LP; das Neves GM; Rodrigues RP; da Silva VB; Eifler-Lima VL; Kawano DF
    Mol Divers; 2017 Aug; 21(3):677-695. PubMed ID: 28523625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
    Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
    Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of new promising Plasmodium falciparum superoxide dismutase allosteric inhibitors through hierarchical pharmacophore-based virtual screening and molecular dynamics.
    Araujo JSC; de Souza BC; Costa Junior DB; Oliveira LM; Santana IB; Duarte AA; Lacerda PS; Dos Santos Junior MC; Leite FHA
    J Mol Model; 2018 Jul; 24(8):220. PubMed ID: 30056475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational and experimental elucidation of Plasmodium falciparum phosphoethanolamine methyltransferase inhibitors: Pivotal drug target.
    Singh J; Vijay S; Mansuri R; Rawal R; Kadian K; Sahoo GC; Kumar M; Sharma A
    PLoS One; 2019; 14(8):e0221032. PubMed ID: 31437171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.
    Kesharwani RK; Singh DV; Misra K
    J Vector Borne Dis; 2013; 50(2):93-102. PubMed ID: 23995310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic library.
    González-Bacerio J; Maluf SEC; Méndez Y; Pascual I; Florent I; Melo PMS; Budu A; Ferreira JC; Moreno E; Carmona AK; Rivera DG; Alonso Del Rivero M; Gazarini ML
    Bioorg Med Chem; 2017 Sep; 25(17):4628-4636. PubMed ID: 28728898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors.
    Owoloye AJ; Ligali FC; Enejoh OA; Musa AZ; Aina O; Idowu ET; Oyebola KM
    PLoS One; 2022; 17(8):e0268269. PubMed ID: 36026508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apicoplast Import Protein Tic20 A Promising Therapeutic Molecular Target for Plasmodium falciparum: An In Silico Approach for Therapeutic Intervention.
    C P K Srimath-Tirumala-Peddinti R; Kusuma SS; Nammi D; Neelapu NRR
    Infect Disord Drug Targets; 2017; 17(3):199-222. PubMed ID: 28595540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in silico strategy for identification of novel drug targets against Plasmodium falciparum.
    Rout S; Patra NP; Mahapatra RK
    Parasitol Res; 2017 Sep; 116(9):2539-2559. PubMed ID: 28755265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Search for novel
    Reghunandanan K; T P A; Krishnan N; K M D; Prasad R; Nelson-Sathi S; Chandramohanadas R
    J Biomol Struct Dyn; 2024 Aug; 42(12):6200-6211. PubMed ID: 37424150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors.
    Chaudhary M; Singh V; Anvikar AR; Sahi S
    Curr Comput Aided Drug Des; 2016; 12(4):282-293. PubMed ID: 27449897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimalarial activity of potential inhibitors of Plasmodium falciparum lactate dehydrogenase enzyme selected by docking studies.
    Penna-Coutinho J; Cortopassi WA; Oliveira AA; França TC; Krettli AU
    PLoS One; 2011; 6(7):e21237. PubMed ID: 21779323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Selective Novel Hits against
    Nyamai DW; Tastan Bishop Ö
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring dual inhibitory role of febrifugine analogues against Plasmodium utilizing structure-based virtual screening and molecular dynamic simulation.
    Pandey RK; Narula A; Naskar M; Srivastava S; Verma P; Malik R; Shah P; Prajapati VK
    J Biomol Struct Dyn; 2017 Mar; 35(4):791-804. PubMed ID: 26984239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Traditional Chinese Medicine Derived Compounds as Wild Type and Mutant Plasmodium falciparum Dihydrofolate Reductase Inhibitors: Induced Fit Docking and ADME Studies.
    Iwaloye O; Elekofehinti OO; Kikiowo B; Fadipe TM; Akinjiyan MO; Ariyo EO; Aiyeku OO; Adewumi NA
    Curr Drug Discov Technol; 2021; 18(4):554-569. PubMed ID: 32729419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of
    Bieri C; Esmel A; Keita M; Owono LCO; Dali B; Megnassan E; Miertus S; Frecer V
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and Identification of Inhibitors Against Glutathione Synthetase, A Potential Drug Target of Plasmodium falciparum.
    Kumar YN; Jeyakodi G; Thulasibabu R; Gunasekaran K; Jambulingam P
    Comb Chem High Throughput Screen; 2015; 18(5):492-504. PubMed ID: 26220832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.